2014
Founding the company
A scientific advisory board began reviewing the business direction in April. Neurogazer was founded in May.
One step, then another.
Understanding the brain.
Exploring human potential.
Help with a report you or your family received.
For questions about an existing BAS service, finding a report or understanding how to read it, contact support@neurogazer.com.
BAS 2.0 is preparing for a post-funding relaunch. A sample MQR is available to explore.
Tell us approximately when and where you received the service and whether you are the recipient or are asking on their behalf. If you remember BAS1016 or BAS5100 on the cover, mention it. If you do not know the report name, the service location and approximate date are enough to start an inquiry.
The Brain Analysis Report (BAR) presents MRI-based measurements and indicators. The Meta Quotient Report (MQR) uses those findings to build a structured interpretation. If a section is unclear, tell us its heading and what you would like explained. See how the MQR is organized ↗
Ask support to check what is available for your existing report. Mention the report type if known. Availability, timing and any fee need to be confirmed for your case before you proceed.
In your first email, describe the issue in a few words. Please leave out scans, report attachments, identity documents and a child’s personal details. For access, correction or deletion of personal information, write to privacy@neurogazer.com.
Company developments and notices for existing shareholders.
Read dated updates here. For a meeting notice, shareholder document or a question about your own holding, contact ir@neurogazer.com.
Within six months of receiving first-close funding, we aim to relaunch BAS 2.0 and deliver 100–300 MQRs. We are designing a way to deliver user-approved context to external AI services.
In its August update, management reported that it had prepared MQRs from existing BAR data for approximately 30 individuals and continued to gather feedback from parents. This work tested whether findings could be explained in a more consistent sequence. Further validation was still needed.
Management also outlined a proposed next step for BAS 3.0: testing whether an AI assistant could use selected findings with the individual’s permission. As of that update, new financing and the proposed research MRI acquisition had yet to be confirmed. View the development roadmap ↗
A study co-authored by Heungyeol Lee of Neurogazer USA appeared in The Journal of Neuroscience. It examined how the timing and spatial patterns of resting-state cortical activity vary across the human lifespan. Read the paper ↗
For a copy of a notice, identify the meeting or document and its date if known. To update your contact details, tell IR how to reach you. Please wait for verification instructions before sending proof of ownership or identification. For the investment thesis and strategic milestones, visit Investor Relations ↗.
In 2015, Neurogazer tested whether it could turn brain analysis into a useful report.
By 2023, it had built a service platform, opened an imaging center and introduced BAS1016 for young people in Korea.
A scientific advisory board began reviewing the business direction in April. Neurogazer was founded in May.
The team tested whether it could generate reports for a commercial service. In December, Neurogazer was selected for Korea’s TIPS startup program and received venture company certification.
Neurogazer established its US company in May. Later that year, it was selected for the TIPS Global Expansion Program and an enterprise growth R&D support program.
Neurogazer introduced an MRI simulator in February and received institutional review board approval in March. In September, the company registered two Korean patents.
The team completed its brain mapping project for Korean children and adolescents, a step toward developing an age-specific brain analysis service.
Neurogazer secured its Series A investment in August.
Neurogazer began developing its US service platform and secured recognition for its in-house research institute. In December, the company raised an additional US$5.5 million.
Neurogazer completed platform development and released brain analysis reports. Its researchers presented three posters at the Society for Neuroscience meeting.
Neurogazer opened the Neurogazer Brain Imaging Center with a Siemens 3T Vida MRI system and hosted the first WNNC conference in January. At its February 2023 pre-launch, BAS1016 (project name, Alcyone) served ages 10–15. The service now serves ages 10–16.
November · BAS 5100 launchNeurogazer launched BAS 5100, extending its brain analysis service to older adults.
Research publication · Human Brain MappingCoordinated anatomical and functional variability in the human brain during adolescence
Co-authored by Heungyeol Lee, affiliated with Neurogazer, Inc. Published online in December 2022 and in the March 2023 issue.
Read the paper ↗Neurogazer developed BASICS & Brain SWOT for its youth service and a beta version of its AI counselor, B.rain. Its researchers presented three posters at the Society for Neuroscience meeting in Chicago.
Neurogazer and the Brain Trainer Association jointly opened the N-Counselor training program to help counselors use MRI-based brain analysis in their work.
Read the Brain Media report (Korean) ↗
July · Brain analysis partnership in UlsanOn July 31, Neurogazer signed a three-party agreement with Dongcheon Dongkang Hospital, a general hospital in Ulsan, and Neulsaeron Anesthesiology and Pain Medicine Clinic. The partners agreed to collaborate on brain analysis services and joint research, with the hospital providing MRI scans, Neurogazer analyzing the data and the clinic delivering the results.
Following its work on adolescence, Neurogazer researchers co-authored a study examining resting-state cortical activity across the lifespan.
Research publication · The Journal of NeuroscienceTemporal and Spatial Scales of Human Resting-State Cortical Activity across the Lifespan
Co-authored by Heungyeol Lee, affiliated with Neurogazer USA, Inc. Published in the January 14, 2026 issue.
Read the paper ↗Neurogazer counts views of its public pages to understand how the website is used. Google Analytics 4 (GA4), which measures visitors and traffic sources, runs only if you allow analytics cookies.
Opening or refreshing Home, BAS · MQR, Personalized AI or Investors in either language adds one view. We keep running totals by date in Korea Standard Time, page and language to show trends over time. Opening a page twice counts as two views.
This counter uses no cookies and continues to count views if you decline analytics cookies. Each count request contains only a predefined page path. The counter stores no IP addresses, cookie identifiers, referral URLs, query parameters or individual browsing histories. Vercel, our hosting provider, may process connection information such as IP addresses when delivering the website.
We load Google’s GA4 tag to measure visitors and site use with cookie identifiers, pages viewed, device and browser information, and traffic sources. We configure the tag to omit query parameters from the page URL and send only the referring site’s origin. UTM source, medium, campaign and content values from a link may be sent separately to measure traffic from newsletters or investor emails. Google signals and advertising personalization are disabled in the website tag.
Open Cookie settings in the footer and choose Allow or Decline. The website does not load GA4 before you choose or while your choice is Decline. If you switch from Allow to Decline, the website stops subsequent GA4 measurement in this browser and attempts to remove its GA cookies. This choice does not erase data already sent.
The ng_analytics cookie remembers your analytics choice in this browser for up to one year. If you select KO or EN, the ng_language cookie remembers your language choice for up to one year. You can choose again after clearing cookies or when using another browser.
When you email us, Neurogazer uses your email address, any name or contact details you provide, your message and attachments to respond. If you need to share an MRI scan or report, contact support first to arrange a suitable way to send it. Processing of service records and participation in research are addressed separately from your website analytics choice.
Access to page view reports and notice management is limited to authorized administrators. Administrator sign-in uses a registered email address and mobile number. Twilio Verify handles SMS verification.
The operator is neurogazer Inc., represented by Heungyeol Lee (Business Registration No. 261-81-12468). You or your authorized representative may request access, correction, deletion, suspension of processing or withdrawal of consent. Email privacy@neurogazer.com with the service involved and your request. We will explain how to verify your identity if needed. Our main phone number in Korea is 1551-3329.
These terms apply to neurogazer.com, operated by neurogazer Inc. Visitors can read about the company and its services, view investor information and notices, and contact the company by email. No visitor account is required.
The website describes BAS · MQR and its development status. It does not process service applications, MRI bookings, payments or report delivery. For services you have already requested, the applicable agreement and law govern delivery, cancellation and refunds. For help with an existing service or report, email support@neurogazer.com.
Brain analysis descriptions and examples on this site provide general information. Consult your healthcare professional about your own diagnosis or treatment.
Business plans, relaunch schedules and listing targets reflect expectations at the time the materials were prepared. Actual outcomes may differ. Viewing investor materials or sending an inquiry does not create an investment application or agreement. Investors and shareholders can contact ir@neurogazer.com.
Rights in the text, images, logos and sample report materials belong to neurogazer Inc. or the relevant rights holder. To reproduce, distribute or use materials commercially beyond quotation or other uses permitted by law, obtain permission from the rights holder. Only authorized administrators may publish notices or access page view reports.
Public page views are counted by date, page and language regardless of your cookie choice. Visitor analytics using Google Analytics 4 starts only if you allow analytics cookies. Read Privacy in the footer for details and use Cookie settings to change your choice.
Using the website does not give consent to use MRI records for research or AI training. If you need to share service records, contact support first to arrange a suitable way to send them.
For questions about these terms or use of the website, email info@neurogazer.com. Disputes about use of the website are governed by the laws of the Republic of Korea. The competent court is determined under applicable law.